Eve & Co Incorporated (TSXV:EVE) announced the launch of its public shares on the TSX Venture Exchange under the ticker symbol “EVE.”
As quoted in the press release:
On June 28, 2018, EVE, formerly named Carlaw Capital V Corp., announced the closing of its qualifying transaction involving the acquisition of Natural MedCo Ltd. (formerly 1600978 Ontario Inc.) by way of a “three-cornered amalgamation” pursuant to the provisions of the Business Corporations Act (Ontario) (the “Qualifying Transaction”). The Qualifying Transaction has now received all final approvals, including that of the TSXV. The total number of issued and outstanding common shares of EVE at the commencement of trading will be 211,144,014.
“Today is a big day for EVE, and we are excited to begin trading on the TSXV. We’re pleased to move forward with EVE as a female-centered cannabis brand and will continue to focus on educating and destigmatizing cannabis use among women. We are increasing our greenhouse capacity from 220,000 [square feet] to 1,000,000 [square feet] to meet our expected demand for the consumer market and look forward to securing distribution deals with various provincial distributors prior to October,” commented Melinda Rombouts, the President and Chief Executive Officer of EVE.